Literature DB >> 21947686

Managing chronic disease in Ireland: hospital admission rates and clinical outcomes in a large ulcerative colitis population.

A N Desmond1, F Shanahan.   

Abstract

BACKGROUND: Health care planning demands a detailed knowledge of the course of chronic diseases in the Irish population. This study describes hospital admission rates, medication use and outcomes in a large cohort of patients with ulcerative colitis attending a tertiary referral centre in Ireland.
METHOD: Four hundred and twenty-four patients who attended during the 18-year period from January 1991 to January 2009 were identified. Baseline demographics, hospital admission, medications required, extent of colitis and date of colectomy were recorded.
RESULTS: More than half (55.4%) of the patients were managed exclusively in an outpatient setting throughout diagnosis and follow-up. Systemic corticosteroids, thiopurines and infliximab were required by 70, 29.5 and 5% of the patients, respectively. Overall 5-year colectomy rate due to failure of medical therapy was 15.8%. Independent predictors of colectomy were hospital admission at first presentation (odds ratio 3.6, p < 0.0001) and pancolitis at diagnosis (odds ratio 2.3, p < 0.01).
CONCLUSIONS: The majority of patients with colitis have an uncomplicated disease course and do not require thiopurines, biologic agents or hospital admission. Principal management at a primary care level may be appropriate in many cases. Colectomy rates at a specialist centre in Ireland compare favourably with international figures.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21947686     DOI: 10.1007/s11845-011-0760-y

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   2.089


  16 in total

1.  The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.

Authors:  W A Faubion; E V Loftus; W S Harmsen; A R Zinsmeister; W J Sandborn
Journal:  Gastroenterology       Date:  2001-08       Impact factor: 22.682

Review 2.  The pattern and outcome of acute severe colitis.

Authors:  Lotte C Dinesen; Alissa J Walsh; Marijana Nedeljkovic Protic; Graham Heap; Fraser Cummings; Bryan F Warren; Bruce George; Neil J M Mortensen; Simon P L Travis
Journal:  J Crohns Colitis       Date:  2010-02-19       Impact factor: 9.071

3.  European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis.

Authors:  E F Stange; S P L Travis; S Vermeire; W Reinisch; K Geboes; A Barakauskiene; R Feakins; J F Fléjou; H Herfarth; D W Hommes; L Kupcinskas; P L Lakatos; G J Mantzaris; S Schreiber; V Villanacci; B F Warren
Journal:  J Crohns Colitis       Date:  2008-01-18       Impact factor: 9.071

4.  Adverse events of IBD therapies.

Authors:  Maria Lia Scribano
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

Review 5.  Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases.

Authors:  Charles N Bernstein; Fergus Shanahan
Journal:  Gut       Date:  2008-05-30       Impact factor: 23.059

6.  Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study).

Authors:  Magne Henriksen; Jørgen Jahnsen; Idar Lygren; Jostein Sauar; Øystein Kjellevold; Tom Schulz; Morten H Vatn; Bjørn Moum
Journal:  Inflamm Bowel Dis       Date:  2006-07       Impact factor: 5.325

7.  The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort.

Authors:  G-T Ho; P Chiam; H Drummond; J Loane; I D R Arnott; J Satsangi
Journal:  Aliment Pharmacol Ther       Date:  2006-07-15       Impact factor: 8.171

8.  The efficacy of low dose azathioprine/6-mercaptopurine in patients with inflammatory bowel disease.

Authors:  Dong Uk Kim; Young-Ho Kim; Beom Jin Kim; Dong Kyung Chang; Hee Jung Son; Poong-Lyul Rhee; Jae J Kim; Jong Chul Rhee
Journal:  Hepatogastroenterology       Date:  2009 Sep-Oct

9.  Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987.

Authors:  E Langholz; P Munkholm; O H Nielsen; S Kreiner; V Binder
Journal:  Scand J Gastroenterol       Date:  1991-12       Impact factor: 2.423

Review 10.  Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.

Authors:  Alexander Teml; Elke Schaeffeler; Klaus R Herrlinger; Ulrich Klotz; Matthias Schwab
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 5.577

View more
  1 in total

Review 1.  Anti-TNF alpha in the treatment of ulcerative colitis: a valid approach for organ-sparing or an expensive option to delay surgery?

Authors:  Gianluca Rizzo; Daniela Pugliese; Alessandro Armuzzi; Claudio Coco
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.